Epilepsy News

LOS ANGELES — Treatment with cannabidiol led to improved seizure and nonseizure outcomes in patients with various forms of epilepsy, data show.

LOS ANGELES — A wearable, behind-the-ear EEG device is feasible for assessment of sleep patterns in young people with Dravet syndrome, according to a poster presented at the American Epilepsy Society annual meeting.

Healio Neurology looks back at the most popular Q&As with industry and specialty experts from the past year.

LOS ANGELES — The ability to utilize more detailed imaging options, as well as to use certain imaging concurrently to detect epileptogenic lesions during presurgical consultation, may lead to better outcomes for patients, according to a speaker.

LOS ANGELES — Zorevunersen led to 75% to 80% seizure reduction in patients with Dravet syndrome, according to Barry S. Ticho, MD, PhD, FACC, chief medical officer of Stoke Therapeutics.

LOS ANGELES — Treatment with cannabidiol in young people with tuberous sclerosis complex led to significant improvements in several cognitive, behavioral and executive domains, data from ongoing survey show.

LOS ANGELES —Multidisciplinary care and physician- or nurse-led models that eliminate geographic disparities are key to optimal outcomes for youths with epilepsy who are transitioning to adulthood, according to a speaker.

LOS ANGELES — For young people with epilepsy, wearable devices may be a feasible method for tracking the effects of antiseizure medications on the autonomic nervous system, according to a presenter.

LOS ANGELES — Patients in Asia, Oceania, Latin America and Africa faced more barriers to genetic testing for epilepsy than those of other regions, which may complicate test interpretations in diverse populations, according to a presenter.